performed in 3 patients with chronic flank pain prior to surgery. Age, BMI, Creatinine, length of follow up, subjective pain score and use of narcotics at last visit were assessed. RESULTS: Of the 6 patients included in the study, 5 underwent auto-transplant. Of these 5, 2 had celiac block prior to surgery, both of which reported alleviation of pain following the block. Of note, the patient who did not undergo auto-transplant also had a successful celiac block but elected for simple nephrectomy for fear of complications with transplantation. All 3 patients who had celiac block and subsequently underwent surgery had resolution of pain and were not on narcotics at last follow-up. Of the remaining 3 patients, 2 were still taking narcotics at last follow up. Mean age was 36.8 yrs., mean BMI was 26.2 and mean follow up was 11.7 mos. All patients had normal renal function at last follow-up with mean serum Cr of 0.88 mg/dL. CONCLUSIONS: Chronic pain syndromes are frustrating for patients, their families, and their physicians. Invasive surgical options such as auto transplant or nephrectomy are considered when conservative measures fail, but not even these methods guarantee pain relief, and can result in significant complication. Based on our experience, we recommend celiac plexus block prior to consideration of more invasive treatment when conservative options fail.
INTRODUCTION AND OBJECTIVES: Clinical regimens of immunosuppression involve different types of agents because the targets of each drug are the halfway points of signaling pathways leading to expression of various essential proteins in immune cells activation. Nuclear factor (NF)-?B is one of key transcriptional factors and is located in the down stream of several signaling pathways activated in immune responses. Therefore pharmacological modulation of NF-?B activities may be of great use for the treatment of allograft rejection. In this study, we investigated for an immunosuppressive effect of a novel NF-?B inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), using a rat kidney transplant model between a highly immune reactive combination.
METHODS: We performed kidney allograft transplant in a rat acute rejection model (WKAH to LEWIS rats, age 6-8 weeks). Rats were randomly assigned into 3 groups (A: control group, not administrated DHMEQ, B: administration of 12 mg/kg DHMEQ, C: administration of 20 mg/kg DHMEQ). DHMEQ was administrated i.p. once daily for consecutive 10 days. Urine and blood samples were collected every each day. The date of anuria was determined as the date of rejection. Transplanted kidney allografts were also explanted on the 4th postoperative day and the infiltration rates of T cells and monocytes were investigated by immunohistochemistry.
RESULTS: DHMEQ significantly prolonged kidney allograft survival. (7.2 AE 1.4 post-transplant days, 13.5 AE 3.4 post-transplant days, 19.4 AE 4.5 post-transplant days, for a control (group A), 12 mg/kg DHMEQ (group B), 20 mg/kg DHMEQ (group C), respectively). There was a reduction of T cell and macrophage infiltration to DHMEQ-treated kidney allografts compared to control allografts. The production of pro-inflammatory cytokines including IL-6, IL-12 p70, TNF-a in the recipients treated with DHMEQ was significantly decreased compared to that in the control group. No remarkable side effects were observed during the experiments.
CONCLUSIONS: DHMEQ is remarkably effective in preventing kidney allograft rejection. DHMEQ can be administrated safely and could be involved in a new immunosuppressive strategy, which allows reducing the dose of current immunosuppressive agents. MP74-16   TRANSURETHRAL RESECTION OR INCISION OF THE  PROSTATE AFTER RENAL TRANSPLANTATION: IS THERE  A SAFER TIME FOR THE PROCEDURE? Afonso Celso Piovesan*, Sao Paulo, Brazil; Rafael Fagionato Locali, São Paulo, Brazil; Marcos Mello, Kleiton G R Yamaçake, Hideki Kanashiro, Gustavo Xavier Ebaid, Ioannis Antonopoulos, Flavio Jota de Paula, William Carlos Nahas, Sao Paulo, Brazil INTRODUCTION AND OBJECTIVES: The age of patients undergoing renal transplantation has increased in the past decades. Symptoms of benign prostate hyperplasia (BPH) are rare in dialysis patients due to low urine excretion. As BPH is very prevalent in elderly men, urologists often have to address unexpectedly symptomatic patients after their kidneys recover function. The aim of this study is to compare urological outcomes and morbidity related to transurethral resection (TURP) or incision of the prostate (TUIP) performed in either the early or the late post-transplant period.
Source of Funding: none
METHODS: Between 1998 and 2016, 3145 renal allograft transplantations were performed in our institution. Fifty patients developed severe prostatic symptoms with no response to drug treatment after recovery of renal function. The patients were divided into two groups in accordance with the time between transplantation and the prostate procedure and were prospectively studied: group I e 18 patients in which TURP/TUIP was performed less than 90 days after transplantation; and group II e 32 patients in which the prostate procedure was performed more than 90 days after transplantation. Urologic parameters analyzed were International Prostate Symptom Score (IPSS), Prostate Specific Antigen (PSA), prostate measurements and PVR (post void residual urine) before and 6 months after surgery. The morbidity was compared based on need of transfusion, presence of urinary tract infection (UTI), time to home discharge and loss of renal function (elevation of creatinine levels).
RESULTS: Both groups were comparable in terms of age (59.8 AE 8.6 vs. 58.5 AE 9.3, p¼0.744), but not in prostate measurement (55.3 AE 37.5 vs. 37.0 AE 12.7, p¼0,001). Furthermore, time of home discharge (9.4 AE 8.5 vs. 4.1 AE 4.5, p¼0.026), the UTI incidence (55.6% vs. 18.8%, p<0,017), and loss of renal function (elevation of creatinine levels -p<0,001) were significantly higher in group I. However, there were no differences between the groups in terms of IPSS in the 6 months (5.9 AE 4.3 vs. 5.1 AE 3,8, p¼0.560), decrease PSA levels (p¼0.568), and PVR in the 6 months (14,2 AE 35,3 ml vs. 26,3 AE 41,4 ml, p¼0.309). No patients need receive transfusions.
CONCLUSIONS: Despite the fact that there was no difference in effectiveness, TURP and TUIP should be avoided in the early post transplantation period due to the increasing risk of infection, the loss of graft function and higher time of home discharge.
Source of Funding: None

MP74-17 RENAL ARTERY DIAMETER IS A SURROGATE MARKER FOR KIDNEY VOLUME IN LIVING KIDNEY DONORS
Arshvin Kesavan*, Bee Choo Tai, Singapore, Singapore; Arun B, Dublin, Ireland; Benjamin Goh, Lata Raman, Vathsala Anantharaman, Ho Yee Tiong, Singapore, Singapore INTRODUCTION AND OBJECTIVES: Donor kidney volume (KV) is an increasingly important parameter evaluated before living kidney donation. It potentially enhances the estimation of glomerular filtration rate before surgery, measures split renal function for selection of the explantation side and prognosticates recipient function following transplantation. However, KV measurements on Computerised Tomographic (CT) scanning requires a manually intensive process of manual or semiautomatic segmentation of kidneys with inter-observer variation. Renal artery diameter (RAD) is an easier marker to measure and this study aims to investigate the relationship between donor RAD and KV.
METHODS: A retrospective review of consecutive patients who underwent living donor nephrectomy between 2010 and 2016 was conducted. In all patients, bilateral kidney volumes were measured based on contrast-enhanced CT scan imaging, using segmentation of Vol. 197, No. 4S, Supplement, Monday, May 15, 2017 THE JOURNAL OF UROLOGY â e1001 functional nephron mass to exclude sinus fat, blood vessels and the pelvi-calyceal system. For the renal artery maximum diameter, we measured the RAD at the vessel cross section just distal to the aortic ostia. Measurements were taken between the tunica intima by direct visualisation on the arterial phase of transverse CT slices. Estimated Glomerular Filtration Rate (eGFR) was determined using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation from serum creatinine levels collected before surgery. RESULTS: 92 consecutive living donor nephrectomy patients were reviewed. After excluding 15 patients with multiple arteries, 77 patients (55.8% Female, 58.4% Chinese) were available for this study. The mean age of the donors was 44.4+/-12.7 years. Controlled hypertension, hyperlipidemia and smoking were present in 9(11.7%), 17 (22.1%) and 7 (9.2%) patients with no other significant co-morbidities. All patients had normal blood pressure (BP) measurements pre-operatively with a mean systolic and diastolic BP of 122.4+/-14.4 and 72.4+/-10.4 mmHg respectively. Mean right and left KVs were 132.8+/-25.9 and 138.9+/-24.8 cm3 respectively. Mean right and left RADs were 4.86+/-0.91 and 5.14+/-0.85 mm respectively On regression analysis, there was a significant association between the right and left RADs and their ipsilateral KVs with a regression coefficient of 7.9 (95% C.I. 1.3-14.5, P¼0.019) and 9.8 (95% C.I. 3.3-16.3, P¼0.004) respectively. Mean eGFR pre-operatively was 105.1+/-14.9 mL/min/1.73 m2. Mean total RAD (the sum of both left and right RAD) was 9.61+/-2.51mm. It was found to be correlated with preoperative eGFR at 0.095. Patients with pre-operative eGFR of < 100 mL/ min/1.73 m2 had a lower total RAD than those with eGFR>100 mL/min/ 1.73 m2 (9.38+/-3.44 mm vs 9.73+/-1.86 mm, p¼n.s.)
CONCLUSIONS: This study demonstrates that renal artery size is positively associated with kidney volume and may be used as a more easily measured surrogate marker for kidney size with its attended implications in living donor transplantation.
Source of Funding: None
MP74-18 THE EFFECT OF THYMOQUINONE ON THE RENAL FUNCTIONS FOLLOWING ISCHEMIA-REPERFUSION INJURY
FAYEZ HAMMAD*, Loay Lubbad, AL AIN, United Arab Emirates INTRODUCTION AND OBJECTIVES: Renal ischemia-reperfusion injury (IRI) is an invariable consequence of several urological conditions and procedures and is associated with alterations in renal functions. Recently, there has been a growing interest in using natural phytochemical compounds as treatment alternatives to conventional drugs in several diseases. This is due to their relatively low toxicity and price and to wide availability. Thymoquinone, an antioxidant phytochemical compound found in the plant Nigella sativa which is heavily consumed in some parts of the world, has been shown to have a protective effect in several renal conditions. However, its effect on the IRIinduced renal hemodynamic and tubular dysfunction has not been investigated yet. Thus, the aim of this study was to investigate the effect of thymoquinone on the alterations in renal functional parameters following warm IRI in the rat.
METHODS: Wistar rats underwent left renal ischemia for 35 minutes. Group-TQ (n¼15) received thymoquinone 10 mg/kg/day (dissolved in a vehicle (corn oil) orally by gavage starting 4 days prior to the IRI and continued 6 days thereafter when the renal functions of the right and left kidneys were measured using clearance techniques. Group-Vx (n¼15) underwent similar protocol but received only the vehicle. In addition, gene expression of some markers of kidney injury and cytokines was measured in the kidney tissue using PCR technique.
RESULTS: IRI affected all hemodynamic and tubular parameters in the affected kidney. So in Group-Vx, the left renal blood flow (RBF), six days following IRI, was 22% of the right RBF (1.27AE0.21 vs. 5.77AE0.54, P¼0.0001). Similarly, the left kidney glomerular filtration rate (GFR) was 15% that of the right non-ischemic kidney (0.18AE0.03 vs. 1.22AE0.07, P¼0.0001). On the other hand, the fractional excretion of sodium (FENa) in the left kidney was significantly higher than the right kidney (2.40AE0.35 vs. 0.59AE0.08, P¼0.0001). When the right non-ischemic kidneys in both groups were compared, all the variables were similar. Thymoquinone attenuated the IRI-related alteration in renal functions so when the left ischemic kidney in Group-TQ and Group-Vx were compared, the left RBF and GFR were significantly higher in Group-TQ (2.02AE0.39 vs. 1.27AE0.21, P¼0.04 and 0.33AE0.08 vs. 0.18AE0.03, P¼0.03, respectively). On the other hand, the left renal FENa was significantly lower in P¼0.04) . Thymoquinone also decreased the gene expressions of KIM-1, NGAL, TNF-a, TGF-b1 and PAI-1 (143AE20 vs. 358AE49, 16AE3 vs. 34AE6, 1.1AE0.2 vs. 2.8AE0.4, 1.6AE0.1 vs. 2.8AE0.1, and 2.4AE0.3 vs. 5.8AE1.0, P<0.05 for all).
CONCLUSIONS: Thymoquinone ameliorated the IRI effect on the hemodynamic and tubular renal functional parameters as well as the expression of some markers of renal injury and pro-inflammatory and pro-fibrotic cytokines indicating a renoprotective effect of this agent on the IRI-induced renal dysfunction with potential clinical implications.
Source of Funding: College of Medicine & Health Sciences, United Arab Emirates University
MP74-19 PROTECTIVE EFFECTS OF REGULATORY T CELLS IN A MURINE MODEL OF RENAL ISCHEMIA-REPERFUSION INJURY
Ryohei Yamamoto*, Mitsuru Saito, Kazuyuki Numakura, Hiroshi Tsuruta, Atushi Maeno, Takamitsu Inoue, Shintaro Narita, Shigeru Satoh, Tomonori Habuchi, Akita, Japan INTRODUCTION AND OBJECTIVES: Solid organ transplantation inevitably leads to ischemia-reperfusion injury (IRI). Regulatory T cells (Tregs) are involved in immunological tolerance at the transplantation site, especially with respect to natural immunity, and also have anti-inflammatory effects. The present study aimed to evaluate whether Tregs protect the kidney from IRI and to explore the possible underlying mechanism.
METHODS: We established the IRI model in male mice (C57BL/6, 10e12 weeks old). Left renal ischemia was performed for 30 min, and then the right kidney was resected following left renal reperfusion. We administered tricostatin A (TsA) and PC61 (anti-CD25 mAb) to increase and decrease the number of Tregs, respectively. Mice were divided into the four groups: the TsA group, the DMSO (vehicle) group, the TsA + PC61 group, and the DMSO + PC61 group. Splenic Treg fractions (CD4[+]Foxp3[+]) were evaluated by flow cytometry at postoperative day (POD) 7. Serum levels of creatinine and different inflammatory cytokines, such as IL-10, IL-6, IL-2, and TNF, were measured by ELISA. The mRNA expressions of Foxp3, IL-10, IL-6, TGF-B, CD80, CD86, and ICAM-1 in the kidney at POD2 were measured by real-time qRT-PCR.
RESULTS: The splenic Treg fraction in the TsA group was significantly higher than those in the other three groups (p < 0.001, respectively). At POD2, the mean level of serum creatinine in the TsA group was significantly lower than those in the other three groups (p < 0.001, respectively). The mean level of serum IL-10 in the TsA group was significantly higher than those in the DMSO/DMSO + PC61 groups (p ¼ 0.01), whereas the mean level of serum IL-6 in the TsA group was significantly lower than those in the DMSO/DMSO + PC61 groups (p ¼ 0.003, respectively). The renal expressions of Foxp3 and IL-10 mRNA were significantly higher in the TsA group than those in the DMSO group (p ¼ 0.003 and p ¼ 0.03, respectively). In contrast to the above findings, the IL-6 mRNA expression was significantly lower in the TsA group than that in the DMSO group (p ¼ 0.016). The mRNA expressions of CD80, CD86, and ICAM-1 in the kidney were significantly lower in the TsA group than those in the DMSO group (p < 0.001, p ¼ 0.018, p ¼ 0.004, respectively).
CONCLUSIONS: Facilitation of Treg expansion by TsA might have some roles in the protection of the kidney from IRI by reducing the expression of co-stimulatory molecules.
